Literature DB >> 20956732

Learning from the placenta: acute atherosis and vascular remodeling in preeclampsia-novel aspects for atherosclerosis and future cardiovascular health.

Anne Cathrine Staff1, Ralf Dechend, Robert Pijnenborg.   

Abstract

Preeclampsia is a common and potentially lethal pregnancy complication for women and offspring. Women who develop preeclampsia also run a long-term augmented risk of cardiovascular disease and premature death, and two theories are discussed. Women developing preeclampsia and persons developing cardiovascular disease may have common risk factors, which are unmasked by the "stress" of pregnancy. Alternatively, a new risk factor might occur de novo during the preeclamptic pregnancy. In preeclampsia, lipid deposition in walls of the maternal uterine arteries leading to the placenta, named spiral arteries, regularly occurs. These vascular lesions resemble early stages of atherosclerosis and are named "acute atherosis" and is thought to regress after delivery. The mechanisms that contribute to acute atherosis in preeclampsia are largely unknown, but are related to the impaired vascular remodeling of the spiral arteries in the first half of pregnancy. One striking feature is that the development of these "atherosclerosis-like" lesions requires a few months in pregnancy and may be partly linked to invasion of trophoblasts (specialized fetally derived placenta cells). We summarize normal and pathological vessel remodeling in pregnancy and discuss similarities and differences between preeclampsia and arteriosclerosis. The transient appearance of acute atherosis of uterine wall spiral arteries seen in pregnancy complications and the molecular interaction between trophoblast, smooth muscle and vascular cells could add important elements to explain arteriosclerosis and stenosis in cardiovascular disease. Further understanding of the process underlying spiral artery atherosis in the months of pregnancy may cast light on development of cardiovascular disease later in life.

Entities:  

Mesh:

Year:  2010        PMID: 20956732     DOI: 10.1161/HYPERTENSIONAHA.110.157743

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  55 in total

Review 1.  [Pregnancy and kidney diseases].

Authors:  M Siekierka-Harreis; L C Rump
Journal:  Internist (Berl)       Date:  2011-10       Impact factor: 0.743

Review 2.  Establishment of the Human Uteroplacental Circulation: A Historical Perspective.

Authors:  Kenna Degner; Ronald R Magness; Dinesh M Shah
Journal:  Reprod Sci       Date:  2016-10-12       Impact factor: 3.060

3.  Maternal serum uric acid concentration is associated with the expression of tumour necrosis factor-α and intercellular adhesion molecule-1 in patients with preeclampsia.

Authors:  J Zhao; D-Y Zheng; J-M Yang; M Wang; X-T Zhang; L Sun; X-G Yun
Journal:  J Hum Hypertens       Date:  2015-10-29       Impact factor: 3.012

Review 4.  A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia.

Authors:  Sandra M Blois; Ralf Dechend; Gabriela Barrientos; Anne Cathrine Staff
Journal:  Cell Mol Life Sci       Date:  2014-09-06       Impact factor: 9.261

5.  Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats.

Authors:  Katrin Wenzel; Augustine Rajakumar; Hannelore Haase; Nele Geusens; Norbert Hubner; Herbert Schulz; Justin Brewer; Lyndsay Roberts; Carl A Hubel; Florian Herse; Lydia Hering; Fatimunnisa Qadri; Carsten Lindschau; Gerd Wallukat; Robert Pijnenborg; Harald Heidecke; Gabriela Riemekasten; Friedrich C Luft; Dominik N Muller; Babette Lamarca; Ralf Dechend
Journal:  Hypertension       Date:  2011-05-16       Impact factor: 10.190

6.  The immunophenotype of decidual macrophages in acute atherosis.

Authors:  Navleen Gill; Yaozhu Leng; Roberto Romero; Yi Xu; Bogdan Panaitescu; Derek Miller; Afrah Arif; Salma Mumuni; Faisal Qureshi; Chaur-Dong Hsu; Sonia S Hassan; Anne Cathrine Staff; Nardhy Gomez-Lopez
Journal:  Am J Reprod Immunol       Date:  2019-03-04       Impact factor: 3.886

Review 7.  Preeclampsia and health risks later in life: an immunological link.

Authors:  Shi-Bin Cheng; Surendra Sharma
Journal:  Semin Immunopathol       Date:  2016-06-23       Impact factor: 9.623

8.  Unique trophoblast stem cell- and pluripotency marker staining patterns depending on gestational age and placenta-associated pregnancy complications.

Authors:  Maja Weber; Claudia Göhner; Sebastian San Martin; Aurelia Vattai; Stefan Hutter; Mario Parraga; Udo Jeschke; Ekkehard Schleussner; Udo R Markert; Justine S Fitzgerald
Journal:  Cell Adh Migr       Date:  2016-02-25       Impact factor: 3.405

9.  Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy.

Authors:  Eleftheria Lefkou; Apostolos Mamopoulos; Themistoklis Dagklis; Christos Vosnakis; David Rousso; Guillermina Girardi
Journal:  J Clin Invest       Date:  2016-07-25       Impact factor: 14.808

Review 10.  Precision test for precision medicine: opportunities, challenges and perspectives regarding pre-eclampsia as an intervention window for future cardiovascular disease.

Authors:  Xin Zhou; Jian-Min Niu; Wen-Jie Ji; Zhuoli Zhang; Peizhong P Wang; Xue-Feng B Ling; Yu-Ming Li
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.